Literature DB >> 10226727

Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer.

W Jiang1, S Hiscox, K Matsumoto, T Nakamura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10226727     DOI： 10.1016/s1040-8428(98)00019-5

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN： 1040-8428            Impact factor:   6.312


× No keyword cloud information.
  57 in total

1.  Differential expression of critical cellular genes in human lung adenocarcinomas and squamous cell carcinomas in comparison to normal lung tissues.

Authors:  Amy L McDoniels-Silvers; Gary D Stoner; Ronald A Lubet; Ming You
Journal:  Neoplasia       Date:  2002 Mar-Apr       Impact factor: 5.715

2.  Early clinical development of ARQ 197, a selective, non-ATP-competitive inhibitor targeting MET tyrosine kinase for the treatment of advanced cancers.

Authors:  Alex A Adjei; Brian Schwartz; Edward Garmey
Journal:  Oncologist       Date:  2011-05-31

Review 3.  Mechanisms of HGF/Met signaling to Brk and Sam68 in breast cancer progression.

Authors:  Alessia Locatelli; Kristopher A Lofgren; Andrea R Daniel; Nancy E Castro; Carol A Lange
Journal:  Horm Cancer       Date:  2012-04       Impact factor: 3.869

4.  FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk.

Authors:  Alexandros Garouniatis; Adamantia Zizi-Sermpetzoglou; Spyros Rizos; Alkiviadis Kostakis; Nikolaos Nikiteas; Athanasios G Papavassiliou
Journal:  Int J Colorectal Dis       Date:  2012-06-26       Impact factor: 2.571

Review 5.  Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy.

Authors:  Megumi Iiizumi; Wen Liu; Sudha K Pai; Eiji Furuta; Kounosuke Watabe
Journal:  Biochim Biophys Acta       Date:  2008-07-22

6.  Ezrin mediates both HGF/Met autocrine and non-autocrine signaling-induced metastasis in melanoma.

Authors:  Liping Huang; Yifei Qin; Qiang Zuo; Kavita Bhatnagar; Jingbo Xiong; Glenn Merlino; Yanlin Yu
Journal:  Int J Cancer       Date:  2017-12-15       Impact factor: 7.396

7.  Preoperative Chemotherapy May Not Influence the Remnant Liver Regenerations and Outcomes After Hepatectomy for Colorectal Liver Metastasis.

Authors:  Yoshihiro Inoue; Kensuke Fujii; Keitaro Tashiro; Masatsugu Ishii; Shinsuke Masubuchi; Masashi Yamamoto; Tetsunosuke Shimizu; Mitsuhiro Asakuma; Fumitoshi Hirokawa; Michihiro Hayashi; Yoshihumi Narumi; Kazuhisa Uchiyama
Journal:  World J Surg       Date:  2018-10       Impact factor: 3.352

8.  Impact of the degree of liver resection on survival for patients with multiple liver metastases from colorectal cancer.

Authors:  Kuniya Tanaka; Hiroshi Shimada; Chizuru Matsumoto; Kenichi Matsuo; Kazuhisa Takeda; Yasuhiko Nagano; Shinji Togo
Journal:  World J Surg       Date:  2008-09       Impact factor: 3.352

9.  Study of critical role of c-Met and its inhibitor SU11274 in colorectal carcinoma.

Authors:  Wei Gao; Xue Bing; MingYan Li; Zhanhua Yang; Ying Li; Hua Chen
Journal:  Med Oncol       Date:  2013-03-28       Impact factor: 3.064

10.  Suppression of the progress of disseminated pancreatic cancer cells by NK4 plasmid DNA released from cationized gelatin microspheres.

Authors:  Toshihiro Kushibiki; Kunio Matsumoto; Toshikazu Nakamura; Yasuhiko Tabata
Journal:  Pharm Res       Date:  2004-07       Impact factor: 4.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.